Shaedon Sharpe: Everything you need to know

Shaedon Sharpe

#17 SG

Portland Trail Blazers

Status

ACTIVE

STATS

Career Averages

PTS

REB

AST

BLK

STL

15.7

4.0

2.2

0.2

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	50	42	29.4	20.8	4.3	2.6	0.1	1.4	2.9	0	2.1	6.1	33.7%	5.8	11.2	51.4%	7.8	17.4	45.2%	3.1	3.9	78.7%	1.0	3.3	2.0	0.9	-50	54.6%
2024-25	72	52	31.3	18.5	4.5	2.8	0.2	0.9	2.1	3	2.0	6.6	31.1%	4.9	8.8	55.7%	6.9	15.3	45.2%	2.6	3.4	78.5%	0.9	3.6	1.7	1.3	-138	55.1%
2023-24	32	25	33.1	15.9	5.0	2.9	0.4	0.9	2.3	1	1.9	5.6	33.3%	3.6	7.9	45.7%	5.5	13.6	40.6%	3.1	3.7	82.4%	1.3	3.7	2.8	1.3	-246	52.4%
2022-23	80	15	22.2	9.9	3.0	1.2	0.3	0.5	1.0	0	1.3	3.5	36.0%	2.6	4.6	55.9%	3.8	8.1	47.2%	0.9	1.3	71.4%	0.8	2.2	1.7	1.1	-297	56.8%
Career	234	134	28.0	15.7	4.0	2.2	0.2	0.8	1.9	4	1.8	5.3	33.2%	4.1	7.7	53.0%	5.9	13.1	45.0%	2.2	2.8	78.1%	1.0	3.0	1.9	1.1	-731	54.9%

Career Averages

PTS

REB

AST

BLK

STL

7.2

1.6

0.6

0.4

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	5	0	13.4	7.2	1.6	0.6	0.4	0.4	0.0	0	0	0.6	2.2	27.3%	2.2	4.6	47.8%	2.8	6.8	41.2%	1.0	1.6	62.5%	0.6	1.0	1.0	3.0	+2	48.0%
Career	5	0	13.4	7.2	1.6	0.6	0.4	0.4	0.0	0	0	0.6	2.2	27.3%	2.2	4.6	47.8%	2.8	6.8	41.2%	1.0	1.6	62.5%	0.6	1.0	1.0	3.0	+2	48.0%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/14	GSW	L 118-111	27	18	4	2	0	3	2	5	1	20.0%	11	6	54.5%	16	7	43.8%	5	3	60.0%	1	3	1.0	+16	4	15	49.5%
10/10	SAC	W 124-123	25	17	6	0	0	0	2	6	2	33.3%	8	4	50.0%	14	6	42.9%	6	3	50.0%	1	5	0.0	-5	5	8	51.1%
10/8	GSW	L 129-123	22	22	6	2	0	0	1	8	4	50.0%	7	5	71.4%	15	9	60.0%	0	0	0.0%	1	5	2.0	+14	2	21	73.3%
Preseason Totals			25.3	19.0	5.3	1.3	0.0	1.0	1.7	6.3	2.3	36.8%	8.7	5.0	57.7%	15.0	7.3	48.9%	3.7	2.0	54.5%	1.0	4.3	0.8	+25	3.7	18.7	57.2%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/10	LAC	W 116-97	15	8	4	2	0	0	2	5	2	40.0%	5	1	20.0%	10	3	30.0%	0	0	0.0%	2	2	1.0	+4	1	3	40.0%
2/6	MEM	W 135-115	13	2	2	2	0	0	1	1	0	0.0%	1	0	0.0%	2	0	0.0%	2	2	100.0%	0	2	2.0	-4	0	5	34.7%
2/3	PHX	L 130-125	31	19	1	1	0	0	1	8	2	25.0%	8	5	62.5%	16	7	43.8%	3	3	100.0%	0	1	1.0	+7	2	10	54.8%
2/1	CLE	L 130-111	31	20	2	3	0	0	4	8	2	25.0%	13	7	53.8%	21	9	42.9%	0	0	0.0%	0	2	0.8	-24	0	7	47.6%
1/30	NYK	L 127-97	27	26	3	3	0	1	3	8	4	50.0%	8	6	75.0%	16	10	62.5%	4	2	50.0%	0	3	1.0	-11	1	25	73.2%
1/27	WAS	L 115-111	34	31	4	2	1	2	3	9	5	55.6%	11	6	54.5%	20	11	55.0%	4	4	100.0%	0	4	0.7	-10	3	29	71.2%
1/26	BOS	L 102-94	34	9	5	3	0	1	3	6	1	16.7%	6	2	33.3%	12	3	25.0%	2	2	100.0%	1	4	1.0	-4	3	4	34.9%
1/23	TOR	L 110-98	32	21	7	4	0	1	3	6	1	16.7%	17	9	52.9%	23	10	43.5%	0	0	0.0%	0	7	1.3	-8	1	16	45.7%
1/22	MIA	W 127-110	33	27	7	3	0	4	6	9	5	55.6%	12	6	50.0%	21	11	52.4%	0	0	0.0%	0	7	0.5	+18	3	20	64.3%
1/18	SAC	W 117-110	34	27	7	0	0	1	5	9	3	33.3%	10	5	50.0%	19	8	42.1%	11	8	72.7%	2	5	0.0	+0	5	19	56.6%
1/17	LAL	W 132-116	29	25	3	4	0	2	2	8	4	50.0%	10	5	50.0%	18	9	50.0%	4	3	75.0%	2	1	2.0	+20	3	22	63.3%
1/15	ATL	W 117-101	33	24	9	5	0	2	5	5	2	40.0%	10	6	60.0%	15	8	53.3%	6	6	100.0%	2	7	1.0	+0	1	31	68.0%
1/13	GSW	L 119-97	28	19	2	2	0	1	1	5	1	20.0%	10	8	80.0%	15	9	60.0%	2	0	0.0%	0	2	2.0	-17	1	16	59.8%
1/11	NYK	L 123-114	34	23	6	3	0	2	4	6	1	16.7%	11	8	72.7%	17	9	52.9%	4	4	100.0%	0	6	0.8	+3	0	23	61.3%
1/9	HOU	W 111-105	34	20	8	5	0	0	0	7	2	28.6%	15	6	40.0%	22	8	36.4%	2	2	100.0%	1	7	0.0	+11	0	20	43.7%
1/7	HOU	W 103-102	34	20	0	3	0	1	3	6	3	50.0%	11	4	36.4%	17	7	41.2%	6	3	50.0%	0	0	1.0	-3	2	10	50.9%
1/5	UTA	W 137-117	27	29	5	7	0	2	1	8	5	62.5%	11	6	54.5%	19	11	57.9%	2	2	100.0%	2	3	7.0	+23	3	32	72.9%
1/3	SAS	W 115-110	28	6	3	3	0	1	4	4	0	0.0%	12	3	25.0%	16	3	18.8%	0	0	0.0%	0	3	0.8	+6	1	5	18.8%
1/2	NOP	W 122-109	30	23	5	1	0	0	3	6	1	16.7%	12	8	66.7%	18	9	50.0%	4	4	100.0%	2	3	0.3	+0	1	19	58.2%
12/31	OKC	L 124-95	28	14	4	1	0	3	3	2	0	0.0%	15	5	33.3%	17	5	29.4%	4	4	100.0%	0	4	0.3	-22	2	3	37.3%
12/29	DAL	W 125-122	33	24	5	5	0	1	3	5	2	40.0%	18	7	38.9%	23	9	39.1%	4	4	100.0%	2	3	1.7	+2	1	19	48.5%
12/28	BOS	W 114-108	31	26	5	1	0	1	3	8	5	62.5%	12	5	41.7%	20	10	50.0%	2	1	50.0%	1	4	0.3	+6	2	18	62.3%
12/26	LAC	L 119-103	32	16	4	2	0	1	1	6	2	33.3%	13	5	38.5%	19	7	36.8%	0	0	0.0%	1	3	2.0	+1	0	9	42.1%
12/23	ORL	L 110-106	26	22	3	2	0	2	3	7	2	28.6%	11	6	54.5%	18	8	44.4%	6	4	66.7%	1	2	0.7	-8	2	16	53.3%
12/22	DET	L 110-102	34	25	3	2	0	5	8	6	1	16.7%	15	10	66.7%	21	11	52.4%	3	2	66.7%	2	1	0.3	-10	2	14	56.0%
12/20	SAC	W 98-93	34	23	4	3	0	2	5	4	2	50.0%	15	8	53.3%	19	10	52.6%	2	1	50.0%	2	2	0.6	+17	3	14	57.8%
12/18	SAC	W 134-133	35	26	4	4	0	1	4	6	4	66.7%	16	7	43.8%	22	11	50.0%	2	0	0.0%	1	3	1.0	-7	2	13	56.8%
12/14	GSW	W 136-131	32	35	3	4	0	4	3	7	5	71.4%	11	7	63.6%	18	12	66.7%	6	6	100.0%	2	1	1.3	+15	2	40	84.8%
12/11	NOP	L 143-120	27	21	3	3	1	0	2	6	4	66.7%	8	4	50.0%	14	8	57.1%	4	1	25.0%	0	3	1.5	-17	4	14	66.6%
12/7	MEM	L 119-96	26	17	2	2	0	1	6	3	3	100.0%	8	2	25.0%	11	5	45.5%	4	4	100.0%	1	1	0.3	-31	1	11	66.6%
12/5	DET	L 122-116	34	28	5	3	0	1	2	7	1	14.3%	18	9	50.0%	25	10	40.0%	7	7	100.0%	2	3	1.5	-11	3	18	49.9%
12/3	CLE	W 122-110	32	20	9	5	0	2	2	5	2	40.0%	13	5	38.5%	18	7	38.9%	6	4	66.7%	2	7	2.5	+13	2	19	48.4%
12/2	TOR	L 121-118	30	23	3	3	0	2	2	3	0	0.0%	15	9	60.0%	18	9	50.0%	6	5	83.3%	0	3	1.5	+2	1	23	55.7%
11/30	OKC	L 123-115	21	7	1	1	0	1	3	3	1	33.3%	4	2	50.0%	7	3	42.9%	2	0	0.0%	0	1	0.3	-18	6	2	44.4%
11/26	SAS	L 115-102	21	11	5	2	1	0	3	3	0	0.0%	5	4	80.0%	8	4	50.0%	4	3	75.0%	0	5	0.7	-13	2	11	56.4%
11/18	PHX	L 127-110	29	29	2	3	0	1	2	6	0	0.0%	18	12	66.7%	24	12	50.0%	7	5	71.4%	0	2	1.5	-20	0	25	53.5%
11/16	DAL	L 138-133	38	36	4	6	0	1	3	9	3	33.3%	23	9	39.1%	32	12	37.5%	11	9	81.8%	2	2	2.0	-3	5	23	48.9%
11/14	HOU	L 140-116	31	19	8	3	1	1	3	5	1	20.0%	11	6	54.5%	16	7	43.8%	8	4	50.0%	1	7	1.0	-22	3	18	48.7%
11/12	NOP	W 125-117	29	35	5	3	0	2	1	7	2	28.6%	11	11	100.0%	18	13	72.2%	7	7	100.0%	0	5	3.0	+20	2	42	83.0%
11/10	ORL	L 115-112	28	31	3	1	0	0	1	5	3	60.0%	13	9	69.2%	18	12	66.7%	7	4	57.1%	0	3	1.0	+4	2	27	73.5%
11/8	MIA	L 136-131	28	21	9	1	0	1	6	8	1	12.5%	11	8	72.7%	19	9	47.4%	3	2	66.7%	5	4	0.2	+15	3	15	51.7%
11/5	OKC	W 121-119	22	18	6	1	1	3	2	5	2	40.0%	10	4	40.0%	15	6	40.0%	4	4	100.0%	2	4	0.5	-5	0	22	53.7%
11/3	LAL	L 123-115	27	23	7	2	0	3	2	7	1	14.3%	10	7	70.0%	17	8	47.1%	8	6	75.0%	1	6	1.0	-1	2	25	56.0%
10/31	DEN	W 109-107	24	19	4	1	1	0	1	7	3	42.9%	7	4	57.1%	14	7	50.0%	3	2	66.7%	2	2	1.0	+9	1	19	62.0%
10/29	UTA	W 136-134	24	18	4	0	0	0	1	8	4	50.0%	6	2	33.3%	14	6	42.9%	2	2	100.0%	0	4	0.0	+2	4	9	60.5%
10/27	LAL	W 122-108	28	16	7	2	0	4	5	6	0	0.0%	10	6	60.0%	16	6	37.5%	4	4	100.0%	2	5	0.4	+21	2	13	45.0%
10/26	LAC	L 114-107	32	19	5	1	0	2	6	9	1	11.1%	15	6	40.0%	24	7	29.2%	4	4	100.0%	4	1	0.2	-5	1	2	36.9%
10/24	GSW	W 139-119	25	17	4	1	0	1	2	6	1	16.7%	9	4	44.4%	15	5	33.3%	6	6	100.0%	0	4	0.5	+0	4	12	48.2%
10/22	MIN	L 118-114	28	15	2	4	0	1	4	9	3	33.3%	11	2	18.2%	20	5	25.0%	2	2	100.0%	0	2	1.0	+0	1	3	35.9%
Regular Season Totals			29.7	21.1	4.4	2.6	0.1	1.4	3.0	6.2	2.1	34.1%	11.3	5.8	51.5%	17.5	7.9	45.4%	4.0	3.1	78.4%	1.0	3.4	0.9	-55	2.0	19.6	54.8%

Postseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/28	SAS	L 114-95	6	5	0	0	0	0	0	2	1	50.0%	3	1	33.3%	5	2	40.0%	0	0	0.0%	0	0	0.0	-7	0	2	50.0%
4/26	SAS	L 114-93	12	8	3	0	0	1	0	2	1	50.0%	4	2	50.0%	6	3	50.0%	2	1	50.0%	1	2	0.0	+5	0	9	58.1%
4/24	SAS	L 120-108	13	4	3	1	1	0	0	0	0	0.0%	5	2	40.0%	5	2	40.0%	2	0	0.0%	2	1	0.0	-4	2	2	34.0%
4/21	SAS	W 106-103	12	9	1	0	1	0	0	3	1	33.3%	2	2	100.0%	5	3	60.0%	2	2	100.0%	0	1	0.0	-1	2	9	76.5%
4/19	SAS	L 111-98	21	10	1	2	0	1	0	4	0	0.0%	9	4	44.4%	13	4	30.8%	2	2	100.0%	0	1	0.0	+9	1	7	36.0%
Postseason Totals			13.4	7.2	1.6	0.6	0.4	0.4	0.0	2.2	0.6	27.3%	4.6	2.2	47.8%	6.8	2.8	41.2%	1.6	1.0	62.5%	0.6	1.0	3.0	+2	1.0	7.2	48.0%

Shaedon Sharpe: Breaking News

Sharpe finished with five points (2-5 FG, 1-2 3Pt) across six minutes during Tuesday's 114-95 loss to the Spurs in Game 5 of the first round of the Western Conference playoffs. Sharpe was basically a non-factor in this series with an average of 13.4 minutes across five games. However, he had a solid regular season, posting averages of 20.8 points, 4.3 rebounds, 2.6 assists and 1.4 steals across 50 appearances. With the offseason coming up, Sharpe will be looking to get back to 100 percent health so he can hit the ground running during training camp.

Sharpe finished with eight points (3-6 FG, 1-2 3Pt, 1-2 FT), three rebounds and one steal in 13 minutes during Sunday's 114-93 loss to San Antonio in Game 4 of the first round of the Western Conference playoffs. Sharpe continues to be used sparingly by the Trail Blazers in this series. Through four games, he's seeing 15.3 minutes per contest with 7.8 points and 2.0 rebounds. It's not helping his case that he's shooting 22.2 percent from beyond the arc thus far.

Sharpe amassed nine points (3-5 FG, 1-3 3Pt, 2-2 FT), one rebound and one block across 13 minutes during Tuesday's 106-103 win over San Antonio in Game 2 of the first round of the Western Conference playoffs. Sharpe continues to handle limited playing time since returning from a two-month absence due to a left fibula stress reaction. Dating back to the regular season, the fourth-year swingman has played 22 minutes or fewer in each of his past five games and may be stuck with a workload restriction until he becomes further removed from such a significant injury.